Correlation Between Champions Oncology and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Inhibrx, you can compare the effects of market volatilities on Champions Oncology and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Inhibrx.
Diversification Opportunities for Champions Oncology and Inhibrx
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Champions and Inhibrx is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Champions Oncology i.e., Champions Oncology and Inhibrx go up and down completely randomly.
Pair Corralation between Champions Oncology and Inhibrx
Given the investment horizon of 90 days Champions Oncology is expected to generate 3.52 times more return on investment than Inhibrx. However, Champions Oncology is 3.52 times more volatile than Inhibrx. It trades about 0.47 of its potential returns per unit of risk. Inhibrx is currently generating about 0.24 per unit of risk. If you would invest 488.00 in Champions Oncology on October 9, 2024 and sell it today you would earn a total of 459.00 from holding Champions Oncology or generate 94.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Champions Oncology vs. Inhibrx
Performance |
Timeline |
Champions Oncology |
Inhibrx |
Champions Oncology and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Champions Oncology and Inhibrx
The main advantage of trading using opposite Champions Oncology and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Inhibrx vs. Ginkgo Bioworks Holdings | Inhibrx vs. CureVac NV | Inhibrx vs. Iovance Biotherapeutics | Inhibrx vs. Krystal Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges |